Commercialized Active Pharmaceutical Ingredient
Product Name
CAS Number
Specification
TP
DMF
Status
Latanoprost
130209-82-4
USP, EP
√
Lenvatinib Mesylate
857890-39-2
In-house
√
Lubiprostone
333963-40-9
In-house
√
Lumateperone Tosylate
1187020-80-9
In-house
Correct
Macitentan
441798-33-0
In-house
√
Maralixibat chloride
228113-66-4
In-house
√
Miglitol
72432-03-2
JP, In-house
√
Nebivolol Hydrochloride
152520-56-4
EP, In-house
√
Olaparib
763113-22-0
In-house
√
Osimertinib mesylate
1421373-66-1
In-house
Q4 2025
Palbociclib
571190-30-2
In-house
√
Pilocarpine Hydrochloride
54-71-7
USP, EP, JP
√
Posaconazole
171228-49-2
In-house
√
Pranlukast
150821-03-7
JP
√
Ramelteon
196597-26-9
In-house
√
Resmetirom
920509-32-6
In-house
Q42025
Ruxolitinib (Phosphate)
941678-49-5&1092939-17-7
In-house
√
Sitafloxacin Hydrate
163253-35-8
In-house
√
Sugammadex Sodium
343306-79-6
In-house
√
Tafluprost
209860-87-7
In-house
√